Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements

1. De Francisco, Á.L.M.
2. Aljama, P.
3. Arias, M.
4. Górriz, J.L.
5. Martínez Castelao, A.
6. Portolés, J.